Jun 15, 2026 08:00AM
Jun 15, 2026 08:00AM
Jun 8, 2026 04:11PM
Jun 8, 2026 04:05PM
Jun 8, 2026 04:05PM
May 28, 2026 04:05PM
May 27, 2026 04:05PM Spruce Biosciences to Participate in Upcoming Conferences in June
May 13, 2026 08:00AM
Apr 27, 2026 09:34AM
Mar 25, 2026 05:35AM
Mar 9, 2026 07:05AM
Feb 18, 2026 07:00AM
Feb 5, 2026 04:05PM
Feb 3, 2026 08:00AM Spruce Biosciences Adds Regulatory and Clinical Development Expertise to Leadership Team
Jan 8, 2026 08:00AM
Dec 23, 2025 06:04AM
Dec 22, 2025 06:20AM
Nov 10, 2025 04:05PM
Oct 21, 2025 02:38PM
Oct 6, 2025 08:00AM
Oct 6, 2025 08:00AM Spruce Biosciences Receives U.S. FDA Breakthrough Therapy Designation for Tralesinidase Alfa Enzyme Replacement Therapy (TA-ERT) in Sanfilippo Syndrome Type B (MPS IIIB)
Aug 14, 2025 04:00PM
Aug 14, 2025 04:00PM
May 6, 2025 04:01PM
Apr 15, 2025 07:02AM
Apr 15, 2025 07:00AM
Nov 11, 2024 08:00AM
Aug 12, 2024 04:01PM Spruce Biosciences Reports Second Quarter 2024 Financial Results and Provides Corporate Updates
Jun 3, 2024 07:00AM
May 13, 2024 04:01PM
Mar 14, 2024 09:11AM
Mar 14, 2024 08:08AM
Mar 13, 2024 04:08PM
Mar 13, 2024 04:01PM
Mar 13, 2024 04:01PM Spruce Biosciences Announces Topline Results from CAHmelia-203 in Adult Classic CAH and CAHptain-205 in Pediatric Classic CAH
Jan 22, 2024 08:00AM
Aug 14, 2023 04:00PM
Aug 10, 2021 04:05PM
May 12, 2021 04:05PM
Mar 22, 2021 04:05PM
Jan 6, 2021 08:06AM
Jan 6, 2021 08:00AM Spruce Biosciences Provides Corporate Update and Outlines Milestones for 2021
Nov 18, 2020 04:05PM

323,114 total articles have been posted to this entity.

Click Here to Sign-Up for StreetInsider.com Premium to View All